Public Health England (PHE) have decided to close the 2017 Reporting Illicit Drug Reactions (RIDR) pilot programme by 28 February 2020. Read more “Pilot for Reporting Illicit Drug Reactions to be discontinued”
Category: Industry news
The latest news from the Pharmaceutical Industry
EMA Management Board meeting highlights the upcoming challenges in 2020
Following three years of relocation and workforce changes, the European Medicines Agency has outlined the challenges to come, in its December Management Board meeting. Read more “EMA Management Board meeting highlights the upcoming challenges in 2020”
What is the benefit of the FDA’s new app for reporting novel uses of infectious disease drugs?
The United States (US) Food and Drug Administration (FDA) have launched an application (app) for global health-care professionals (HCPs) to report novel uses of existing medicine for patients with rare and difficult-to-treat infectious diseases. Read more “What is the benefit of the FDA’s new app for reporting novel uses of infectious disease drugs?”
New “smart pill” technology shows 100% success rate
A new “smart pill” bottle which prompts patients to take their medications on time and notifies doctors when it has been dispensed, has shown 100% reliability in improving medication adherence. Read more “New “smart pill” technology shows 100% success rate”
The need for cross-sectoral, global cooperation to fight antimicrobial resistance
The statement emphasises the role of medicines regulators in efficiently bringing safe, effective and high quality antimicrobial products to the market, as well as minimising the regulatory barriers which can prevent access to essential treatments. Read more “The need for cross-sectoral, global cooperation to fight antimicrobial resistance”
The latest advancements on the use of artificial intelligence in drug development
Approximately 50% of late-stage clinical trials fail due to ineffective drug targets, meaning only 15% of drugs advance from Phase II trials to approval. Artificial intelligence (AI) can help to enhance drug development by making more accurate predictions in novel areas of biology and chemistry. Read more “The latest advancements on the use of artificial intelligence in drug development”
The US FDA have finalised two guidances on guidewires, catheters and delivery systems
The United States (US) Food and Drug Administration (FDA) have issued two final guidances regarding performance tests and labelling considerations for intravascular guidewires, catheters and delivery systems. Read more “The US FDA have finalised two guidances on guidewires, catheters and delivery systems”
Highlights from the recent PRAC meeting
The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) have unveiled highlights of their meeting from 30th September – 3rd October 2019. Read more “Highlights from the recent PRAC meeting”
How would an international price index (IPI) work to lower drug prices in the US?
House speaker Nancy Pelosi has unveiled a plan to lower sky-high prescription drug prices in the United States (US). Read more “How would an international price index (IPI) work to lower drug prices in the US?”
Are you aware of the Department of Health and Social Care’s (DHSC) work with the industry on plans to minimise any medical supply disruption following a no-deal Brexit?
The Medicines and Healthcare Regulatory Agency (MHRA) have released guidance summarising their approach and actions to be taken by businesses supplying the United Kingdom (UK) with medicines from the European Union (EU), Iceland, Lichtenstein or Norway. Read more “Are you aware of the Department of Health and Social Care’s (DHSC) work with the industry on plans to minimise any medical supply disruption following a no-deal Brexit?”